Fig. 2From: Enhanced production of amyrin in Yarrowia lipolytica using a combinatorial protein and metabolic engineering approachTriterpenoid titers in the engineered Y. lipolytica in YPD. Prevailing genes in the MVA pathway, namely HMG1, ERG20, ERG9 and ERG1, were overexpressed singly and in combination. A Amyrin titers with single gene overexpression. B Squalene titers with single gene overexpression. C Amyrin titers with multiple gene overexpression. D Squalene titers with multiple gene overexpression. Control strain: Po1g ΔKU70. The codon-optimized CrMAS gene was used in all the engineered strains. Amyrins were quantified after 5 days of cultivation in shake flasks. Each engineered strain was named based on the genes that were overexpressed. The codon-optimized CrMAS gene: C; HMG1 gene: H; ERG1 gene: E1; ERG9 gene: E9; ERG20 gene: E20. For example, the Po1g KCHE20 strain refers to Y. lipolytica Po1g ΔKU70 overexpressing CrMAS, HMG1 and ERG20. All values presented are the mean of three biological replicates ± standard deviationBack to article page